
U.S. Healthcare Staffing and Scheduling Software Market Size, Share, Trends, Industry Analysis Report By Product Type, By Deployment Model, By Specialty, By End User – Market Forecast, 2025–2034
Description
The U.S. healthcare staffing and scheduling software market size is expected to reach USD 3.30 Billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Healthcare Staffing and Scheduling Software Market Size, Share, Trends, Industry Analysis Report By Product Type, By Deployment Model, By Specialty, By End User; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The U.S. healthcare staffing and scheduling software market is experiencing strong growth due to the rising demand for efficient workforce management, growing complexity of hospital operations, and the increasing emphasis on optimizing staff allocation to improve patient care delivery.
The market is further accelerated by the rapid integration of cloud-based solutions, interoperability with electronic health record (EHR) systems, and the expansion of telehealth services that require seamless workforce coordination. Vendors are focusing on developing intelligent, user-friendly, and scalable platforms that enable predictive scheduling, support real-time analytics, and improve operational efficiency.
U.S. Healthcare Staffing and Scheduling Software Market Report Highlights
Based on product type, the care provider scheduling segment dominated the market in 2024, propelled by the rising need for streamlined workforce allocation, effective shift management, and accurate overtime tracking within hospitals and healthcare systems.
In terms of deployment model, the cloud-based segment held the largest share in 2024, supported by scalability, reduced upfront costs, and seamless integration with electronic health record (EHR) systems and telehealth platforms.
Based on specialty, the primary care segment led the market in 2024, due to large patient volumes, growing demand for efficient appointment coordination, and the optimization of workforce resources in general healthcare services.
Based on end user, the hospitals segment dominated the market in 2024, attributed to the complex workforce structures, diverse patient care needs, and the increasing adoption of digital tools to enhance efficiency in large-scale healthcare facilities.
A few key global players include AdvancedMD, Inc., American Medical Software, Inc., AMN Healthcare Services, Inc., Aya Healthcare, Inc., Bullhorn, Inc., Caspio, Inc., Connecteam, Inc., Infor, Inc., Kyruus Health, Inc., Oracle America, Inc., QGenda, LLC, Q-nomy Inc., RLDatix North America, Inc., ShiftMed, LLC, and Workday, Inc.
Polaris Market Research has segmented the market report on the basis of product type, deployment mode, specialty, and end user:
By Product Type Outlook (Revenue, USD Billion, 2020–2034)
Patient Scheduling
Care Provider Scheduling
Others
By Deployment Mode Outlook (Revenue, USD Billion, 2020–2034)
Cloud-Based
On-Premise
Hybrid
By Specialty Outlook (Revenue, USD Billion, 2020–2034)
Primary Care
Dentistry
Behavioral and Mental Health
Others
By End User Outlook (Revenue, USD Billion, 2020–2034)
Hospitals
Clinics
Ambulatory Surgical Centers
Telehealth Providers
Others
The U.S. healthcare staffing and scheduling software market is experiencing strong growth due to the rising demand for efficient workforce management, growing complexity of hospital operations, and the increasing emphasis on optimizing staff allocation to improve patient care delivery.
The market is further accelerated by the rapid integration of cloud-based solutions, interoperability with electronic health record (EHR) systems, and the expansion of telehealth services that require seamless workforce coordination. Vendors are focusing on developing intelligent, user-friendly, and scalable platforms that enable predictive scheduling, support real-time analytics, and improve operational efficiency.
U.S. Healthcare Staffing and Scheduling Software Market Report Highlights
Based on product type, the care provider scheduling segment dominated the market in 2024, propelled by the rising need for streamlined workforce allocation, effective shift management, and accurate overtime tracking within hospitals and healthcare systems.
In terms of deployment model, the cloud-based segment held the largest share in 2024, supported by scalability, reduced upfront costs, and seamless integration with electronic health record (EHR) systems and telehealth platforms.
Based on specialty, the primary care segment led the market in 2024, due to large patient volumes, growing demand for efficient appointment coordination, and the optimization of workforce resources in general healthcare services.
Based on end user, the hospitals segment dominated the market in 2024, attributed to the complex workforce structures, diverse patient care needs, and the increasing adoption of digital tools to enhance efficiency in large-scale healthcare facilities.
A few key global players include AdvancedMD, Inc., American Medical Software, Inc., AMN Healthcare Services, Inc., Aya Healthcare, Inc., Bullhorn, Inc., Caspio, Inc., Connecteam, Inc., Infor, Inc., Kyruus Health, Inc., Oracle America, Inc., QGenda, LLC, Q-nomy Inc., RLDatix North America, Inc., ShiftMed, LLC, and Workday, Inc.
Polaris Market Research has segmented the market report on the basis of product type, deployment mode, specialty, and end user:
By Product Type Outlook (Revenue, USD Billion, 2020–2034)
Patient Scheduling
Care Provider Scheduling
Others
By Deployment Mode Outlook (Revenue, USD Billion, 2020–2034)
Cloud-Based
On-Premise
Hybrid
By Specialty Outlook (Revenue, USD Billion, 2020–2034)
Primary Care
Dentistry
Behavioral and Mental Health
Others
By End User Outlook (Revenue, USD Billion, 2020–2034)
Hospitals
Clinics
Ambulatory Surgical Centers
Telehealth Providers
Others
Table of Contents
125 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Neurovascular Devices Market Insights
- 4.1. Neurovascular Devices Market – Market Snapshot
- 4.2. Neurovascular Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Aging Global Population Increasing the Incidence of Neurovascular Disorders
- 4.2.1.2. Growing Demand for Minimally Invasive Neurovascular Procedures
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Costs of Advanced Devices and Limited Availability of Skilled Neurointerventional Specialists
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Neurovascular Devices Market Trends
- 4.6. Value Chain Analysis
- 5. Global Neurovascular Devices Market, by Device Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 5.3. Stenting Systems
- 5.3.1. Global Neurovascular Devices Market, by Stenting Systems, by Region, 2020-2034 (USD Billion)
- 5.4. Embolization Devices
- 5.4.1. Global Neurovascular Devices Market, by Embolization Devices, by Region, 2020-2034 (USD Billion)
- 5.5. Neurothrombectomy Devices
- 5.5.1. Global Neurovascular Devices Market, by Neurothrombectomy Devices, by Region, 2020-2034 (USD Billion)
- 5.6. Support Devices
- 5.6.1. Global Neurovascular Devices Market, by Support Devices, by Region, 2020-2034 (USD Billion)
- 6. Global Neurovascular Devices Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 6.3. Cerebral Aneurysms
- 6.3.1. Global Neurovascular Devices Market, by Cerebral Aneurysms, by Region, 2020-2034 (USD Billion)
- 6.4. Ischemic Stroke
- 6.4.1. Global Neurovascular Devices Market, by Ischemic Stroke, by Region, 2020-2034 (USD Billion)
- 6.5. Other Application
- 6.5.1. Global Neurovascular Devices Market, by Other Application, by Region, 2020-2034 (USD Billion)
- 7. Global Neurovascular Devices Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Global Neurovascular Devices Market, by Hospitals, by Region, 2020-2034 (USD Billion)
- 7.4. Specialty Clinics
- 7.4.1. Global Neurovascular Devices Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
- 7.5. Other End User
- 7.5.1. Global Neurovascular Devices Market, by Other End User, by Region, 2020-2034 (USD Billion)
- 8. Global Neurovascular Devices Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Neurovascular Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Neurovascular Devices Market – North America
- 8.3.1. North America: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Neurovascular Devices Market – U.S.
- 8.3.4.1. U.S.: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Neurovascular Devices Market – Canada
- 8.3.5.1. Canada: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4. Neurovascular Devices Market – Europe
- 8.4.1. Europe: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Neurovascular Devices Market – UK
- 8.4.4.1. UK: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Neurovascular Devices Market – France
- 8.4.5.1. France: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.5.3. France: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Neurovascular Devices Market – Germany
- 8.4.6.1. Germany: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Neurovascular Devices Market – Italy
- 8.4.7.1. Italy: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Neurovascular Devices Market – Spain
- 8.4.8.1. Spain: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Neurovascular Devices Market – Netherlands
- 8.4.9.1. Netherlands: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Neurovascular Devices Market – Russia
- 8.4.10.1. Russia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Neurovascular Devices Market – Rest of Europe
- 8.4.11.1. Rest of Europe: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5. Neurovascular Devices Market – Asia Pacific
- 8.5.1. Asia Pacific: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Neurovascular Devices Market – China
- 8.5.4.1. China: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.4.3. China: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Neurovascular Devices Market – India
- 8.5.5.1. India: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.5.3. India: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Neurovascular Devices Market – Malaysia
- 8.5.6.1. Malaysia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Neurovascular Devices Market – Japan
- 8.5.7.1. Japan: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Neurovascular Devices Market – Indonesia
- 8.5.8.1. Indonesia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Neurovascular Devices Market – South Korea
- 8.5.9.1. South Korea: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Neurovascular Devices Market – Australia
- 8.5.10.1. Australia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Neurovascular Devices Market – Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6. Neurovascular Devices Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Neurovascular Devices Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Neurovascular Devices Market – UAE
- 8.6.5.1. UAE: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Neurovascular Devices Market – Israel
- 8.6.6.1. Israel: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Neurovascular Devices Market – South Africa
- 8.6.7.1. South Africa: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Neurovascular Devices Market – Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7. Neurovascular Devices Market – Latin America
- 8.7.1. Latin America: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Neurovascular Devices Market – Mexico
- 8.7.4.1. Mexico: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Neurovascular Devices Market – Brazil
- 8.7.5.1. Brazil: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Neurovascular Devices Market – Argentina
- 8.7.6.1. Argentina: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Neurovascular Devices Market – Rest of Latin America
- 8.7.7.1. Rest of Latin America: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Acandis GmbH
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Asahi Intecc Co., Ltd.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Balt Group SAS
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Johnson & Johnson
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Kaneka Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Medtronic plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. MicroPort Scientific Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Penumbra, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. phenox GmbH
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Rapid Medical Ltd.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Stryker Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Terumo Corporation
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.